Business Description
West Pharmaceutical Services Inc
NAICS : 339112
SIC : 3841
ISIN : BRW2STBDR007
Share Class Description:
BSP:W2ST34: BRDRDescription
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.61 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | 0.41 | |||||
| Interest Coverage | 117.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 18.34 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EBITDA Growth Rate | 17.9 | |||||
| 3-Year EPS without NRI Growth Rate | 19.3 | |||||
| 3-Year FCF Growth Rate | 11.9 | |||||
| 3-Year Book Growth Rate | 16.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.44 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.6 | |||||
| 9-Day RSI | 78.59 | |||||
| 14-Day RSI | 76.76 | |||||
| 6-1 Month Momentum % | 12.95 | |||||
| 12-1 Month Momentum % | 12.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 82.49 | |||||
| Days Sales Outstanding | 64.94 | |||||
| Days Payable | 44.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.16 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| 3-Year Dividend Growth Rate | 5.8 | |||||
| Forward Dividend Yield % | 0.18 | |||||
| 5-Year Yield-on-Cost % | 0.22 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 3.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.87 | |||||
| Operating Margin % | 20.44 | |||||
| Net Margin % | 17.37 | |||||
| FCF Margin % | 11.17 | |||||
| ROE % | 18.16 | |||||
| ROA % | 13.61 | |||||
| ROIC % | 18.1 | |||||
| ROC (Joel Greenblatt) % | 27.61 | |||||
| ROCE % | 19.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 47.97 | |||||
| Forward PE Ratio | 45.42 | |||||
| PE Ratio without NRI | 47.83 | |||||
| Shiller PE Ratio | 60.9 | |||||
| Price-to-Owner-Earnings | 56.29 | |||||
| PEG Ratio | 2.17 | |||||
| PS Ratio | 8.32 | |||||
| PB Ratio | 8.52 | |||||
| Price-to-Tangible-Book | 8.91 | |||||
| Price-to-Free-Cash-Flow | 74.46 | |||||
| Price-to-Operating-Cash-Flow | 34.09 | |||||
| EV-to-EBIT | 39.55 | |||||
| EV-to-Forward-EBIT | 34.61 | |||||
| EV-to-EBITDA | 31.48 | |||||
| EV-to-Forward-EBITDA | 27.41 | |||||
| EV-to-Revenue | 8.08 | |||||
| EV-to-Forward-Revenue | 7.47 | |||||
| EV-to-FCF | 72.23 | |||||
| Price-to-Projected-FCF | 3.39 | |||||
| Price-to-DCF (Earnings Based) | 1.75 | |||||
| Price-to-DCF (FCF Based) | 2.73 | |||||
| Price-to-Median-PS-Value | 1.36 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.99 | |||||
| Price-to-Graham-Number | 4.35 | |||||
| Price-to-Net-Current-Asset-Value | 37.41 | |||||
| Earnings Yield (Greenblatt) % | 2.53 | |||||
| FCF Yield % | 1.37 | |||||
| Forward Rate of Return (Yacktman) % | 17.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
West Pharmaceutical Services Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 14,967.371 | ||
| EPS (TTM) (R$) | 1.002 | ||
| Beta | -0.58 | ||
| Volatility % | 24.14 | ||
| 14-Day RSI | 76.76 | ||
| 14-Day ATR (R$) | 0.280921 | ||
| 20-Day SMA (R$) | 54.158 | ||
| 12-1 Month Momentum % | 12.03 | ||
| 52-Week Range (R$) | 45.75 - 57.72 | ||
| Shares Outstanding (Mil) | 2,534.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
West Pharmaceutical Services Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
West Pharmaceutical Services Inc Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
West Pharmaceutical Services Inc Frequently Asked Questions
What is West Pharmaceutical Services Inc(BSP:W2ST34)'s stock price today?
The current price of BSP:W2ST34 is R$55.00. The 52 week high of BSP:W2ST34 is R$57.72 and 52 week low is R$45.75.
When is next earnings date of West Pharmaceutical Services Inc(BSP:W2ST34)?
The next earnings date of West Pharmaceutical Services Inc(BSP:W2ST34) is 2025-02-14 Est..
Does West Pharmaceutical Services Inc(BSP:W2ST34) pay dividends? If so, how much?
The Dividend Yield %  of West Pharmaceutical Services Inc(BSP:W2ST34) is 0.16% (As of Today), Highest Dividend Payout Ratio of West Pharmaceutical Services Inc(BSP:W2ST34) was 0.26. The lowest was 0.08. And the median was 0.2. The  Forward Dividend Yield % of West Pharmaceutical Services Inc(BSP:W2ST34) is 0.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers